MLS, NWSL, WNBA Cannabis Policy 2026 — Soccer & Women's Pro
MLS follows WADA (150 ng/mL in-competition), NWSL doesn't test, WNBA tests with limited fines. Brittney Griner's Russia detention reframed every overseas-play conversation.
Three Leagues, Three Postures
The U.S. soccer and women's professional landscape contains three of the most structurally divergent cannabis policies in major sport. MLS still tests under WADA-aligned in-competition rules. The NWSL doesn't test at all and explicitly allows cannabis-brand sponsorships. The WNBA tests with limited fines under a 2020 CBA whose 2025 renegotiation is the next inflection point. None of the three has matched the NBA's full 2023 removal — partly because of FIFA-WADA alignment for MLS, partly because of CBA timing for the WNBA, and partly because the NWSL got there first by simply never adopting cannabis testing in the first place.
MLS: WADA-Aligned, In-Competition Only Prohibited in-competition
The MLS-MLSPA collective-bargaining agreement most recently agreed in February 2021 — a multi-year extension running through the 2027 season — preserves a substance-of-abuse program that follows WADA standards because MLS is a FIFA-affiliated competition. Random in-season and off-season testing for the WADA Prohibited List applies. The 150 ng/mL THC-COOH threshold governs, in-competition only. Through May 2026, no MLS-equivalent of the NBA or MLB removal has been negotiated. The next CBA window after 2027 is the most realistic opportunity for a structural change.
For the WADA in-competition rules that govern MLS testing, see WADA & Olympics. For the implications of the in-competition definition for off-season cannabis users, see In-Competition vs Out-of-Competition.
NWSL: No Testing, Sponsorships Allowed Removed from list
The National Women's Soccer League does not test for cannabis under its 2022 CBA and explicitly permits cannabis-brand sponsorships — the most permissive structural posture in U.S. team sports. The league's posture distinguishes it sharply from MLS within American soccer, and matches the NBA's 2023 model in functional permissiveness while predating it.
WNBA: Tested with Limited Fines Prohibited in-competition
The WNBA continues to test for cannabis under its CBA (ratified 2020, currently being renegotiated for a 2026+ term as of late 2025). Limited use is allowed before fines escalate — a tiered structure rather than the NBA's full removal. The asymmetry with the NBA on its sister league is a recurring point in WNBA labor and equity discussions; with the WNBA's wage scale already a flashpoint and overseas play a structural feature of the calendar, cannabis policy intersects with multiple other open issues. The 2025–2026 CBA renegotiation is the operative window for any change. See Women's Pro Sports & Cannabis for fuller treatment.
The Brittney Griner Case
The conversation about cannabis in women's pro basketball cannot be separated from the Brittney Griner case. On February 17, 2022, the two-time Olympic gold medalist and WNBA All-Star was detained at Sheremetyevo airport on cannabis-vape-cartridge possession. Griner had a medical-cannabis prescription in Arizona but, in Russia, the vape cartridges constituted criminal possession.
On August 4, 2022, a Russian court sentenced Griner to nine years in a penal colony. She was released on December 8, 2022 in a prisoner swap for arms dealer Viktor Bout. The case has reframed every WNBA-overseas conversation about cannabis-related travel risk — particularly given that overseas play has long been a structural part of the women's-basketball wage equation. For the full case timeline and policy implications, see Brittney Griner: Russia Detention. For travel-risk analysis broadly, see International Athletes & Cannabis.
Putting the Three Side-by-Side
For an athlete weighing post-collegiate or pro options, the three leagues' postures matter:
- An MLS player operates on the WADA in-competition framework — the same rules a USADA-tested track athlete navigates — with all the washout-protocol implications.
- An NWSL player operates with no league cannabis testing and the most permissive sponsorship environment.
- A WNBA player operates with a tested-but-limited-fine structure under a 2020 CBA whose successor is being negotiated — with overseas-play geography adding the Griner-precedent dimension to the U.S. policy question.